79°
Feels Like: 80°
67°
86°
67°
ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The...
Read More »
ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The...
Read More »
By Ben Hirschler LONDON (Reuters) - Genomics and particle physics - offering different perspectives on the fundamental nature of lif...
Read More »By Deena Beasley (Reuters) - An exciting class of new cancer drugs may boost patients' odds for survival, but healthcare providers a...
Read More »(Reuters) - Johnson & Johnson is voluntarily recalling about 32 million packages of its birth control pill Cilest in Europe, Asia an...
Read More »By Laura Zuckerman (Reuters) - Human ancestors in Africa about 3.4 million years ago expanded their diets beyond the leaves and frui...
Read More »
By Lisa Maria Garza DALLAS (Reuters) - Breast cancer charity Susan G. Komen for the Cure, which suffered a publicity backlash last y...
Read More »(Reuters) - Aveo Pharmaceuticals Inc said it would cut about 62 percent of its workforce, or 140 jobs, to focus on developing its mo...
Read More »By Soyoung Kim and Greg Roumeliotis NEW YORK (Reuters) - Private equity firms KKR & Co LP, Warburg Pincus LLC and Cinven Ltd are wei...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite the U.S. government offering hefty financial incentives to doctors for using...
Read More »
